Willis Lab
News & Impact

You are here

HDAC6: A Target for Regeneration Following Injury in the Nervous System

April 1, 2011 to February 29, 2016
GRANT: 
Federal
Funding Status: 
Completed Project
Funding Agency: 
National Institutes of Health (NIH)
Funding Institute: 
National Institute of Neurological Disorders and Stroke (NINDS)
Grant Number: 
R01NS071056
Published Grant: 
NIH RePORT

Goals

In the Specific Aims of this Application, we will examine the function of HDAC6, as well as the 1-tubulin acetylating enzyme, Elp3, in growth-inhibited axons. We will examine the extent to which their activities modulate the acetylation level of 1-tubulin and the role of 1-tubulin deacetylation in microtubule destabilization and axonal regeneration failure. We also will test whether HDAC6 plays a role in axon regeneration failure in vivo and whether increasing 1-tubulin acetylation by HDAC inhibition enhances axonal regeneration after spinal cord injury.

Investigators

Brett C. Langley, Ph.D.
Former Lab Director
Neuronal Epigenetics Laboratory
Associate Professor
Role: 
Principal Investigator
Dianna's Photo
Associate Director
Lab Director
Laboratory for Axonal and RNA Biology
Assistant Professor
Role: 
Co-Investigator

Associated

Conditions & Recovery

Motor Recovery Icon
Write and walk again.
Spinal Cord Injury icon
Around the world, between 300,000 and 500,000 people are living with a SCI.

Research Methods